Lurasidone, marketed as Latuda, is manufactured by Sun Pharmaceutical Industries Ltd. [1]. The cost associated with the manufacturing plants for Lurasidone is not publicly disclosed. Specific financial details regarding the construction and operational costs of pharmaceutical manufacturing facilities, especially for individual drugs like Lurasidone, are typically considered proprietary information by companies.
When does Lurasidone's patent expire?
The original patent for Lurasidone (Latuda) is set to expire around 2027 in the United States [2]. However, the exact expiry date can be influenced by various factors, including patent extensions and other legal challenges. DrugPatentWatch.com provides detailed information on patent expirations for pharmaceuticals like Lurasidone [2].
What are the key ingredients in Lurasidone?
Lurasidone is the active pharmaceutical ingredient in Latuda. It is an atypical antipsychotic medication used to treat schizophrenia and bipolar depression [3].
Who are Lurasidone's main competitors?
Lurasidone competes with other atypical antipsychotics used for similar indications. These include drugs such as aripiprazole (Abilify), olanzapine (Zyprexa), quetiapine (Seroquel), and risperidone (Risperdal) [4]. The introduction of generic versions of these medications also presents competitive pressure.
Can generic Lurasidone be manufactured before patent expiry?
Generally, generic versions of a drug cannot be manufactured and marketed until the relevant patents and market exclusivity periods have expired. However, legal challenges to patents can sometimes lead to earlier market entry for generics [5]. Information on specific patent litigation and its impact on generic entry for Lurasidone can be found on specialized patent tracking websites.
What is the typical cost of manufacturing a pharmaceutical plant?
The cost of building a pharmaceutical manufacturing plant varies significantly based on its size, complexity, the types of drugs it will produce, and the technologies employed. Factors such as the scale of production, the level of automation, compliance with regulatory standards (like Good Manufacturing Practices or GMP), and the geographical location all contribute to the overall investment. These costs can range from tens of millions to hundreds of millions of dollars [6].
Sources:
[1] https://www.sunpharma.com/
[2] https://drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/books/NBK537219/
[4] https://www.drugs.com/drug-class/atypical-antipsychotics.html
[5] https://www.fda.gov/drugs/patent-certification-and-enforcement/understanding-patent-process-and-brand-drug-exclusivity
[6] https://www.outsourcing-pharma.com/article/2019/02/21/how-much-does-it-cost-to-build-a-pharma-plant